October 23, 2016 2:12 AM ET


Company Overview of RFS Pharma, LLC

Company Overview

As of November 25, 2014, RFS Pharma, LLC was acquired by Cocrystal Pharma, Inc. RFS Pharma, LLC, a clinical-stage bio-pharmaceutical company, focuses on developing therapeutics for the treatment of hepatitis viruses and emerging viruses. The company uses its nucleoside chemistry solutions to develop drugs to combat infections caused by drug-resistant HIV and hepatitis viruses. Its products include amdoxovir for the treatment of HIV-1 infections; analogs that are effective against noroviruses; and nucleoside prodrug technology solutions. RFS Pharma, LLC was founded in 2004 and is based in Tucker, Georgia.

1860 Montreal Road

Tucker, GA 30084

United States

Founded in 2004





Key Executives for RFS Pharma, LLC

RFS Pharma, LLC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RFS Pharma, LLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.